Clinical Trial Update: The Effects of Cannabis Use in People With Schizophrenia on Clinical, Neuropsychological and Physiological Phenotypes [Phase 1, Phase 2]

View source ↗

Summary

A terminated Phase 1/2 clinical trial evaluated the effects of cannabis use in people with schizophrenia; results were posted in 2015. The sponsor was the Unive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Cannabis (Cannabis)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Schizophrenia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2015-09-21